Ceres Nano Overview
- Year Founded
-
2008

- Status
-
Private
- Employees
-
40

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.4M
- Investors
-
14
Ceres Nano General Information
Description
Developer of biomarker capture particle technology products designed to deliver innovative products, address critical diagnostic needs and provide better patient outcomes. The company's products capture enriches and preserves biomarkers, enabling health institutions to quickly and accurately detect diseases such as cancer, cardiac and infectious diseases, resulting in improved patient outcomes and reduced health care costs.
Contact Information
Website
www.ceresnano.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- 9460 Innovation Drive
- Manassas, VA 20110
- United States
+1 (800) 000-0000
Ceres Nano Timeline
Ceres Nano Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
16. Grant | 01-Dec-2022 | $1.4M | 000.00 | Completed | Generating Revenue | |
15. Later Stage VC (Series B) | 09-Sep-2022 | 000 | 000.00 | 0000 | Completed | Generating Revenue |
14. Grant | 21-Apr-2021 | 00.00 | 000.00 | Completed | Generating Revenue | |
13. Debt - PPP | 09-Apr-2020 | 000.00 | Completed | Generating Revenue | ||
12. Grant | 31-Jan-2020 | 00000 | 000.00 | Completed | Generating Revenue | |
11. Grant | 03-Jun-2019 | 00000 | 000.00 | Completed | Generating Revenue | |
10. Grant | 00000 | 000.00 | Completed | Generating Revenue | ||
9. Later Stage VC | 07-Feb-2019 | 00000 | 000.00 | 000.00 | Completed | Generating Revenue |
8. Later Stage VC (Series A) | 30-May-2018 | $8.5M | $11M | 0000 | Completed | Generating Revenue |
7. Grant | 12-Dec-2017 | $50K | $2.5M | Completed | Generating Revenue |
Ceres Nano Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Seed 2 | 80,000 | $0.001000 | $5 | $5 | 1x | $2.32 | 1.33% | |
Seed 1 | 400,000 | $0.001000 | $2.5 | $2.5 | 1x | $2.5 | 3.07% |
Ceres Nano Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of biomarker capture particle technology products designed to deliver innovative products, address critical di
Diagnostic Equipment
Manassas, VA
40
As of 2023
000.00
0000000000
000.00
Ceres Nano Competitors (13)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
P-Cure | Venture Capital-Backed | Shilat, Israel | 00 | 0000 | 000000 - 000 | 0000 |
0000000 0000000000 | Venture Capital-Backed | Maastricht, Netherlands | 0 | 000.00 | 00000 00000 | 000.00 |
000000000 00000000 | Venture Capital-Backed | Rockville, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
0000000000000 | Venture Capital-Backed | Eagan, MN | 00 | 000.00 | 000000000 - | 000.00 |
0000000000 | Formerly VC-backed | Paris, France | 000 | 00000 | 00000000 | 00000 |
Ceres Nano Patents
Ceres Nano Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200340893-A1 | Hydrogel particle-enabled large volume fluid processing device and system | Inactive | 21-Dec-2018 | 0000000000 | |
EP-2776150-A1 | Absorbent dried biofluid collection substrates | Inactive | 10-Nov-2011 | 0000000000 | |
EP-2776150-A4 | Absorbent dried biofluid collection substrates | Inactive | 10-Nov-2011 | G01N33/543 | 0 |
Ceres Nano Executive Team (3)
Ceres Nano Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Emanuel Petricoin III | Self | Board Member | 000 0000 |
Ian Wright | Self | Board Member | 000 0000 |
Ross Dunlap | Ceres Nano | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Scott Gazelle Ph.D | GreyBird Ventures | Board Member | 000 0000 |
Tom Miller | GreyBird Ventures | Chairman | 000 0000 |
Ceres Nano Signals
Ceres Nano Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Birchaven Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
Streck | Corporation | Minority | 000 0000 | 000000 0 | |
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
Bay Area Lyme Fund | Corporation | Minority | 000 0000 | 000000 0 | |
GreyBird Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |